Company Name
Pmv Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN:
US69353Y1038
CIK:
0001699382
CUSIP:
69353Y103
Currency:
USD
Full Time Employees:
47
Phone:
609 642 6670
Website:
https://www.pmvpharma.com
Fiscal Year End:
December
IPO Date:
Sep 25, 2020
Description:
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is rezatapopt, an orally available small molecule that potently and selectively correct p53 misfolding caused by p53 mutation, Y220C, while sparing wild-type p53. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.
Address:
400 Alexander Park Drive, Princeton, NJ, United States, 08540